Related Experiment Video
Updated: Apr 22, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.5K
VMAT planning study in rectal cancer patients
Jun Shang1, Wei Kong2, Yan-yang Wang3
1Department of Radiation Oncology, General Hospital of Ningxia Medical University, No.804 Shengli Str, Yinchuan, 750004, Ningxia, China. shangjun138118@163.com.
Radiation Oncology (London, England)
|October 17, 2014
Summary
Double-arc volumetric-modulated arc therapy (DA-VMAT) offers superior target dose homogeneity for rectal cancer but shows reduced organ-at-risk sparing, particularly for the small bowel, compared to intensity-modulated radiation therapy (IMRT). VMAT techniques significantly decrease treatment time and monitor units.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Rectal cancer treatment planning requires precise radiation delivery.
- Intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) are advanced radiation techniques.
- Comparing dosimetric differences between IMRT and VMAT (single-arc and double-arc) is crucial for optimizing rectal cancer treatment.
Purpose of the Study:
- To compare the dosimetric outcomes of fixed-field IMRT, single-arc VMAT (SA-VMAT), and double-arc VMAT (DA-VMAT) for rectal cancer patients.
- To evaluate target volume coverage, dose homogeneity, and organ-at-risk (OAR) sparing across the three techniques.
- To assess treatment efficiency by comparing monitor units (MU) and delivery time.
Main Methods:
- Retrospective analysis of 15 rectal cancer patients previously treated with IMRT.
- Generation of three treatment plans per patient: IMRT, SA-VMAT, and DA-VMAT.
- Dosimetric analysis using dose-volume histograms (DVHs) for planning target volume (PTV) and OARs (small bowel, bladder, femoral heads).
Main Results:
- DA-VMAT demonstrated superior PTV dose coverage and homogeneity compared to IMRT and SA-VMAT.
- SA-VMAT and IMRT showed comparable target dose coverage, but SA-VMAT offered improved V95 and V107.
- VMAT techniques, especially DA-VMAT, resulted in significantly increased small bowel dose (V15) compared to IMRT, despite reduced MU and treatment time.
Conclusions:
- DA-VMAT provides the most homogeneous PTV dose distribution for rectal cancer.
- VMAT techniques offer significant reductions in treatment time and MU.
- Further investigation is needed to address the inferior normal tissue sparing, particularly for the small bowel, with VMAT in rectal cancer treatment.

